AMPARO HALECKI: Open Payments
NPI 1386088144 · ELIZABETH CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 24 payments from 9 companies in 2025. Trend: 2023 $417 · 2024 $813 · 2025 $620
Food & beverage: $531Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 5 | $181 |
| PFIZER INC. | 6 | $99 |
| Novo Nordisk Inc | 4 | $92 |
| Boston Scientific Corporation | 2 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $65 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Amgen Inc. | 2 | $29 |
| ABIOMED | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OPSUMIT, ELIQUIS, Wegovy, WATCHMAN FLX, Kerendia, INJECTAFER, REPATHA, OPSYNVI.
Industry payments across NC — which companies pay providers there.
